Edition:
Deutschland

Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

110.42USD
13 Dec 2019
Change (% chg)

$-2.05 (-1.82%)
Prev Close
$112.47
Open
$112.82
Day's High
$113.75
Day's Low
$109.72
Volume
547,793
Avg. Vol
734,274
52-wk High
$141.81
52-wk Low
$92.57

About

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab... (more)

Buy/Sell

Sell Hold Buy
1.85 Mean rating from 20 analysts

Overall

Beta: 1.67
Market Cap(Mil.): $24,888.56
Shares Outstanding(Mil.): 221.29
Dividend: --
Yield (%): --

UPDATE 3-Alexion Pharma rejects Elliott's push for "proactive sale"

Dec 6 Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously rejected hedge fund Elliott Management's push for a "proactive sale" process of the entire company because it would not be in the best interest of shareholders.

Alexion Pharmaceuticals rejects Elliott push for "proactive sale"

Dec 6 Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously decided against hedge fund Elliott Management's push for a "proactive sale" process, saying it would not be in the best interest of shareholders.

US STOCKS-Apple, Boeing lead Wall Street higher

* Indexes up: Dow 0.09%, S&P 0.09%, Nasdaq 0.01% (Updates market action, adds comment)

US STOCKS-Wall St propped up by Apple, Boeing

* Indexes up: Dow 0.24%, S&P 500 0.11%, Nasdaq 0.04% (Updates to open, adds background)

US STOCKS-Wall St eyes subdued open as Caterpillar, Texas Instruments disappoint

* Futures: Dow flat, S&P 500 off 0.08%, Nasdaq up 0.07% (Updates market action, adds comments)

REFILE-US STOCKS-Futures drop as Caterpillar, Texas Instruments weigh

Oct 23 Wall Street was set to open lower on Wednesday after warnings from Caterpillar and Texas Instruments rekindled worries about a global economic slowdown due to U.S.-China trade tensions.

UPDATE 1-FDA approves Alexion's Ultomiris for another rare blood disease

Oct 18 The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said.

FDA approves Alexion's Ultomiris for another rare blood disease

Oct 18 The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said.

Deals of the day-Mergers and acquisitions

Oct 16 The following bids, mergers, acquisitions and disposals were reported by 2000 hours GMT on Wednesday:

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.24%
Rohstoffe +0.50%
Industrie +0.54%
Konjunktur abhängige Waren & Dienstleistungen +0.62%
Konjunktur unabhängige Waren & Dienstleistungen +0.21%
Finanzindustrie +0.15%
Pharma +0.50%
Technologie -0.02%
Telekommunikation +1.13%

Nachrichten aus der Wirtschaft